МУЛТИДИСЦИПЛИНАРНЫЙ ПОДХОД К ДОПОЛНИТЕЛЬНОМУ ЛЕЧЕНИЮ КОМОРБИДНОЙ УРОЛОГИЧЕСКОЙ ПАТОЛОГИИ ПРИ РАКЕ ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ
Main Article Content
Abstract
This article explores the importance of using a multidisciplinary approach to the management of concomitant urological pathology in patients with prostate cancer. It discusses the relationship between prostate cancer and urological conditions, provides a literature review, suggests effective methods of integrated care, and provides insight into potential outcomes and debates. Ultimately, it highlights the importance of collaboration between healthcare professionals to optimise patient outcomes.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
Prabhu Das I, et al. Cancer. 2018; 124:3656–67. https://doi. org/10.1002/cncr.31394. [PubMed]
Tang C, et al. Cancer. 2020; 126:506–14. https://doi. org/10.1002/cncr.32570. [PubMed]
Gomella LG, et al. J Oncol Pract. 2010; 6:e5–e10. https://doi. org/10.1200/jop.2010.000071. [PubMed]
Kaps B, et al. Cancer Med. 2020; 9:8754–64. https://doi. org/10.1002/cam4.3482. [PubMed]
Bagley AF, et al. JAMA Netw Open. 2020; 3:e201255. https://doi.org/10.1001/jamanetworkopen.2020.1255. [PubMed]
Tang C, et al. Int J Radiat Oncol Biol Phys. 2021; 109:1286– 95. https://doi.org/10.1016/j.ijrobp.2020.11.055. [PubMed]
Wallis CJD, et al. Br J Cancer. 2018; 118:1399–405. https:// doi.org/10.1038/s41416-018-0071-4. [PubMed]
Lesslie M, et al. Diagnostics (Basel). 2017; 7:55. https://doi. org/10.3390/diagnostics7040055. [PubMed]